AMSUS Thought Leadership Forums are special events featuring a panel of Executive Advisory Council (EAC)/federal health leaders and subject matter experts from our Executive Advisory Board (EAB). These events focus on a single, important health issue affecting military, public, and Veterans health.
Protecting Patients and Individuals Against Opioid Overdose and its Associated Costs to Our Healthcare Systems
1 November 2022 │ 12:00 – 5:30pm ET │ The Madison Hotel, 1177 15th St NW, Washington, DC
AMSUS’s Thought Leadership Forums bring together leaders from the federal healthcare system and industry to address a current challenge facing healthcare today. This Forum will engage panelists in meaningful discussion about the opioid crisis, what is being done at the corporate level and what is being done at the federal health level to address, mitigate and manage the epidemic. Through rich conversation, these diverse leaders will provide insights to the problem at hand and reach consensus on a path forward.
- Learn of the unique needs and perspectives our industry leaders are facing
- Listen to meaningful discussions as corporate leaders and federal health leaders discuss the challenges
- Take away valuable insight to help evaluate the impact of current programs and to identify areas for enhancement within your own health system
- Network with colleagues from industry and federal health systems
Tentative Agenda:
12:00 – 1:00pm – Registration/Networking
1:00 – 1:15pm – Introduction by AMSUS leadership
1:15 – 2:15pm – Presentations from Industry SMEs
2:15 – 2:30pm – Break
2:30 – 3:00pm – Federal Leadership Introduction, Opening Statements & Discussions
3:00 – 4:30pm – Q&A with Federal Leadership/Closing Remarks
4:30 – 5:30pm – Networking reception
Light refreshments will be served. We hope to see you there!
Panelists:
LTG R. Scott Dingle, MS, USA, Army Surgeon General and Commanding General, US Army Medical Command
MG Rich Stone, MC USA (ret), Former Acting Under Secretary for Health, US Department of Veterans Affairs
VADM Vivek H. Murthy, MD, MBA, US Surgeon General (invited)
Rahul Gupta, MD, MPH, MBA, FACP, Director of National Drug Control Policy (invited)
Peter Caravella, MD, FACS, Intuitive Surgical
Don Stader, MD FACEP, Swedish Medical Center in Englewood, CO
Gay Owens, PharmD, MBA, Sr Director Global Medical Affairs, Emergent Biosolutions
Steve Kearney, PharmD, Global Medical Director, SAS Health Solutions
After this presentation, attendees will be able to:
- Understand the opioid epidemic and the role of naloxone
- Develop criteria to identify patients at risk for opioid-induced respiratory depression (OIRD), utilizing real-world evidence
- Model the real-world evidence data within each participant’s own health system to evaluate impact of current programs and to identify areas for enhancement. Compare geographic differences due to co-prescribing laws or similar other programs
Dress Code: Business Dress recommended
Fee: $35 members/$60 non-members
